Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmicrofilament motor activity

MYH9 MYO1D MYO1E MYO10

3.29e-0638544GO:0000146
GeneOntologyMolecularFunctioncalmodulin binding

ORAI1 MYH9 MYO1D MYO1E MYO10 ASPM

3.56e-05230546GO:0005516
GeneOntologyMolecularFunctioncytoskeletal protein binding

MYH9 MYO1D MYO1E HAP1 MYO10 SYNE1 UNC5C TUBGCP3 FES DYSF VBP1

1.44e-0410995411GO:0008092
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYH9 MYO1D MYO1E MYO10

2.92e-04118544GO:0003774
GeneOntologyMolecularFunctionactin filament binding

MYH9 MYO1D MYO1E MYO10 SYNE1

3.65e-04227545GO:0051015
GeneOntologyCellularComponentmyosin complex

MYH9 MYO1D MYO1E MYO10

1.88e-0559564GO:0016459
MousePhenoeye inflammation

ORAI1 MYH9 SPNS2 SYNE1 FES

3.51e-0673455MP:0001851
DomainIQ_motif_EF-hand-BS

MYH9 MYO1D MYO1E MYO10 SCN7A ASPM

2.02e-0790536IPR000048
DomainIQ

MYH9 MYO1D MYO1E MYO10 ASPM

1.71e-0671535PF00612
DomainIQ

MYH9 MYO1D MYO10 SCN7A ASPM

3.30e-0681535SM00015
DomainMyosin_head_motor_dom

MYH9 MYO1D MYO1E MYO10

3.97e-0638534IPR001609
DomainMYOSIN_MOTOR

MYH9 MYO1D MYO1E MYO10

3.97e-0638534PS51456
DomainMyosin_head

MYH9 MYO1D MYO1E MYO10

3.97e-0638534PF00063
DomainMYSc

MYH9 MYO1D MYO1E MYO10

3.97e-0638534SM00242
DomainIQ

MYH9 MYO1D MYO1E MYO10 ASPM

6.52e-0693535PS50096
DomainEYA_fam

EYA4 EYA3

4.72e-054532IPR028472
DomainEYA_dom

EYA4 EYA3

4.72e-054532IPR006545
DomainMyosin_TH1

MYO1D MYO1E

1.64e-047532PF06017
DomainMyosin_TH1

MYO1D MYO1E

1.64e-047532IPR010926
DomainTH1

MYO1D MYO1E

1.64e-047532PS51757
DomainP-loop_NTPase

MYH9 CTPS2 MYO1D MYO1E MYO10 ASPM WSCD2 CHD8 ABCA7

5.77e-04848539IPR027417
DomainMyosin-like_IQ_dom

MYH9 ASPM

1.31e-0319532IPR027401
Domain-

MYH9 ASPM

1.31e-03195324.10.270.10
Pubmed

Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis.

HOXD3 UNC5C

2.55e-06256235709926
Pubmed

Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair.

MYH9 DYSF

7.63e-06356222253476
Pubmed

Mitochondria control store-operated Ca2+ entry through Na+ and redox signals.

ORAI1 SLC8B1

7.63e-06356228219928
Pubmed

Differential localization and dynamics of class I myosins in the enterocyte microvillus.

MYO1D MYO1E

1.52e-05456220089841
Pubmed

AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination.

AICDA AFF3

1.52e-05456236001653
Pubmed

Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.

EYA4 EYA3

1.52e-05456219901965
Pubmed

Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

MYO1D MYO10 SYNE1 WSCD2

2.19e-051015649872452
Pubmed

EYA4, a novel vertebrate gene related to Drosophila eyes absent.

EYA4 EYA3

3.80e-0565629887327
Pubmed

Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia.

MYO1D MYO1E

3.80e-05656212486594
Pubmed

A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.

MYH9 MYO1D MYO1E

5.35e-054556322114352
Pubmed

Mapping of unconventional myosins in mouse and human.

MYO1D MYO1E MYO10

6.50e-05485638884266
Pubmed

beta-Catenin is a Nek2 substrate involved in centrosome separation.

MYH9 ASPM

7.09e-05856218086858
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

RANBP2 MYH9 CHD8 CLINT1 EYA3 POLK

7.92e-0544456634795231
Pubmed

WDFY4 is required for cross-presentation in response to viral and tumor antigens.

MYH9 MYO1D MYO1E CARD9

1.19e-0415656430409884
Pubmed

Phenotypic annotation of the mouse X chromosome.

CTPS2 PORCN VBP1

1.33e-046156320548051
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

MYH9 AICDA CARD9 MYO10 SPNS2 TEX38 AFF3 ASPM CCDC127

1.53e-04124256930973865
Pubmed

The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.

MYH9 MYO1D MYO1E MYO10 CLINT1

1.86e-0432856523398456
Pubmed

Temporally divergent regulatory mechanisms govern neuronal diversification and maturation in the mouse and marmoset neocortex.

CUX2 HLF

1.96e-041356235915179
Pubmed

Tagging genes with cassette-exchange sites.

XPO5 CHD8 EYA3 FBXL19 DYSF

2.06e-0433556515741177
Pubmed

Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.

MYH9 MYO1E

2.29e-04145628022818
Pubmed

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.

RANBP2 MYH9 MYO1D CLINT1 VBP1

2.62e-0435356527545878
Pubmed

The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.

MYH9 MYO10 SYNE1 CHD8

2.91e-0419756420811636
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

ASPM CLINT1 ITGA9 POLK DYSF

2.97e-0436356514691545
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

RANBP2 MYH9 XPO5 TUBGCP3 CHD8 CLINT1

3.42e-0458256620467437
Pubmed

Prediction of the coding sequences of mouse homologues of FLJ genes: the complete nucleotide sequences of 110 mouse FLJ-homologous cDnas identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MYH9 DYSF ZNF598

3.56e-048556315449545
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

MYO1D ASPM EYA3 POLK RUFY1 FAM111B

3.61e-0458856638580884
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ORAI1 SLC8B1 MYO1E MYO10 CHD8 FBXL19 DYSF ABCA7

3.72e-04110556835748872
Pubmed

Disruptions in asymmetric centrosome inheritance and WDR62-Aurora kinase B interactions in primary microcephaly.

CUX2 ASPM

3.83e-041856228272472
Pubmed

TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target.

MYH9 ZNF598

3.83e-041856234729304
Pubmed

Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.

SYNE1 ARNT2

4.28e-041956218711365
Pubmed

Genome-wide association identifies ATOH7 as a major gene determining human optic disc size.

MYH9 UNC5C

4.28e-041956220395239
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

RANBP2 AFF3 CLINT1 POLK

4.58e-0422256437071664
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

CUX2 XPO5 SYNE1 CHD8

4.81e-0422556412168954
Pubmed

UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.

RANBP2 ZNF598

5.24e-042156237422473
Pubmed

EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway.

MYH9 MYO1E

5.24e-042156233029523
Pubmed

CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis.

UNC5C ASPM

5.24e-042156222154806
Pubmed

Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.

RANBP2 CARD9 MYO10

5.56e-049956327746211
Pubmed

Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.

CUX2 HOXD3 HLF ARNT2

7.25e-0425156429031500
Pubmed

Conserved transcriptional regulation by BRN1 and BRN2 in neocortical progenitors drives mammalian neural specification and neocortical expansion.

CUX2 ASPM

7.46e-042556239271675
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

RANBP2 MYH9 ASPM CLINT1

7.80e-0425656433397691
Pubmed

Dachshund homologues play a conserved role in islet cell development.

EYA4 EYA3

8.71e-042756220869363
Pubmed

UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.

RANBP2 MYH9 CLINT1 RUFY1

9.12e-0426756433417871
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

RANBP2 EPM2A EYA4 XPO5 EYA3 ZNF598 VBP1

9.28e-0497456728675297
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

RANBP2 MYO1D MYO1E CLINT1 DYSF ZNF598

1.07e-0372456636232890
InteractionPSME3 interactions

MRPL20 MYH9 EPM2A AICDA TUBGCP3 CHD8 FBXL19 RUFY1

8.79e-06398538int:PSME3
GeneFamilyEYA transcriptional coactivator and phosphatases

EYA4 EYA3

2.31e-0543621044
GeneFamilyMyosins, class I

MYO1D MYO1E

1.07e-0483621097
CoexpressionAtlasDevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500

MYH9 CUX2 EYA4 TRIM35 UNC5C SCN7A WSCD2 ITGA9

8.94e-06412548gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500

MYH9 EYA4 MYO10 TRIM35 ARNT2

3.81e-05149545gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9

EPM2A HLF AFF3 SCN7A PLCD4

9.46e-071415651baa054c2ae3b446d1954244b7fbf8af824ef345
ToppCellmild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2)

CUX2 EPM2A MYO1E HAP1 IL3RA

2.17e-06167565bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCellmild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

CUX2 EPM2A MYO1E HAP1 IL3RA

2.24e-06168565968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HOXD3 UNC5C HLF ARNT2 SCN7A

3.98e-061895657eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CUX2 MYO1E AFF3 FES IL3RA

4.64e-061955654cbc36fb3ef9aef61367d3b37070a9a85fae1418
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYH9 MYO10 SPNS2 DYSF IL3RA

5.12e-061995650d63da0afa93741c37609d879941de202d9ac86c
ToppCellMacroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

MYO1D MYO1E SPNS2 UNC5C DYSF

5.25e-062005654dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCellMacroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic

MYO1D MYO1E SPNS2 UNC5C DYSF

5.25e-0620056526b989e30bbbaf30904ced03f6aae3dea25c732c
ToppCellMacroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic

MYO1D MYO1E SPNS2 UNC5C DYSF

5.25e-062005651314664c1721e9ecb1e2c3482a039044b0fe50a9
ToppCellMacroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic

MYO1D MYO1E SPNS2 UNC5C DYSF

5.25e-062005658b229f095fc113aecfc94b64862a9e0fdcc363ce
ToppCellMacroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

MYO1D MYO1E SPNS2 UNC5C DYSF

5.25e-06200565272909f4354f3ae22e2b2f8f35970e6b0e92cfe2
ToppCellMacroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic

MYO1D MYO1E SPNS2 UNC5C DYSF

5.25e-062005655f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca
ToppCellfacs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 HAP1 SYNE1 ZNF598

4.66e-0515856412661763d1c309106801cb710c04cd2b62d16cba
ToppCellfacs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 HAP1 SYNE1 ZNF598

4.66e-05158564e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCellfacs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 HAP1 SYNE1 ZNF598

4.66e-051585640792c39e6fc0745095af7812de2d50949540d60f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO1D MYO1E SYNE1 UNC5C

4.78e-051595645ca96db4281abb5f646150ccf36adc66ab201c78
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9

HLF AFF3 SCN7A PLCD4

4.90e-051605648a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

MYO1D MYO10 SCN7A PLCD4

4.90e-051605640293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

MYO1D MYO10 SCN7A PLCD4

4.90e-051605643eaae86fa08f7651021316f8e5811bf48055591e
ToppCellTCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9

HLF AFF3 SCN7A PLCD4

4.90e-05160564d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9

HLF AFF3 SCN7A PLCD4

4.90e-05160564c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCellTCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9

EPM2A HLF SCN7A PLCD4

5.14e-05162564b115b5799137122bd60696f8ae2aebadad6cd044
ToppCelldroplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPM2A CARD9 SYNE1 FES

5.27e-05163564bc37c5d9f48b16096d5313657563f3ec84028c8c
ToppCellTCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9

EPM2A HLF SCN7A PLCD4

5.65e-0516656468e6fc7c0040bbe48a93f96ecf28afffdc626845
ToppCellTCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9

AICDA UNC5C AFF3 SCN7A

5.92e-051685645ce3129a023a48a3d7e6b9306c1fc5addfef9675
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO1D MYO1E SYNE1 UNC5C

6.20e-05170564876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO1D MYO1E SYNE1 UNC5C

6.20e-051705641f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCellCOVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass

CUX2 MYO1E AFF3 IL3RA

6.34e-05171564779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCellCOVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass

CUX2 MYO1E AFF3 IL3RA

6.34e-05171564debbb071d260639b16269c94d172766908325c58
ToppCell10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue

WSCD2 CLINT1 ITGA9 IL3RA

6.78e-05174564a5838821bba2be790d32331ff529d466e9974268
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-6|TCGA-Pancreas / Sample_Type by Project: Shred V9

CARD9 FES GNMT IL3RA

6.78e-051745649ad13d4613c4f80bdd8033cc1ecf60eda7c0e6e5
ToppCell10x5'-blood-Mast|blood / Manually curated celltypes from each tissue

WSCD2 CLINT1 ITGA9 IL3RA

6.78e-051745643a8a253213b207e3ff56f94a74996b8d9ad47aa1
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYO1D SPNS2 AFF3 ITGA9

7.41e-05178564f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CUX2 MYO1E AFF3 IL3RA

7.57e-05179564124da6f882968dc0d05f3edd8f3b4d61617cc214
ToppCellCOVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

SYNE1 UNC5C ARNT2 WSCD2

7.57e-05179564e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CUX2 MYO1E AFF3 IL3RA

7.57e-05179564edc5ef693dc4e7ea70717b77fb908fc784dce3a2
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CUX2 HOXD3 ITGA9 DYSF

7.90e-05181564b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell(2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class

MYO1D MYO1E HLF AFF3

7.90e-0518156456ae86072858c156681507aecd1bc6cb0a3372d2
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 UNC5C ARNT2 WSCD2

7.90e-051815645f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

EYA4 MYO10 UNC5C SCN7A

7.90e-051815649ede19228ba5c0668a9c06c915510b95585216ef
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CUX2 HOXD3 ITGA9 DYSF

7.90e-05181564cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CUX2 HOXD3 ITGA9 DYSF

7.90e-05181564ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 UNC5C ARNT2 WSCD2

7.90e-05181564c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DNAJC25 UNC5C HLF SCN7A

8.25e-051835642f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCellfacs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCN7A WSCD2 ITGA9 IL3RA

8.42e-05184564fea4fe648e9749177d0783443dc26a7df5807883
ToppCellfacs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCN7A WSCD2 ITGA9 IL3RA

8.42e-0518456496a8a0a190bc293655fe7d80cbed8119c0da25f2
ToppCellfacs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCN7A WSCD2 ITGA9 IL3RA

8.42e-05184564780eb72da43527f0c72effac3423ec7384f05f20
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

EYA4 HOXD3 MYO1E MYO10

8.60e-05185564a0a629e5d2b65f670ea907bd3f5e3caf17687d8f
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 UNC5C ARNT2 WSCD2

8.60e-0518556434fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYH9 SPNS2 DYSF IL3RA

8.60e-051855640ab1be455f2cd883c9d1522ca78112c37833352e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 UNC5C ARNT2 WSCD2

8.60e-051855648816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCellPBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

8.78e-0518656431df1eafa3010bc1be6fc4d4689f1393d69b6b13
ToppCellPBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

8.78e-05186564eaa431ccd4cdd36fe06a44987603ec9979025aa8
ToppCellPBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

8.78e-05186564b95be984e308d4f9061274a35995ec558d434e74
ToppCellPBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

8.78e-051865648f7949740286f64e034d1eb533ebc2c6f71ae966
ToppCellPBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

8.78e-0518656495c7318e521fb6aa02e244b1e81e6b2a62107756
ToppCellPBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

8.78e-05186564b70cd94c651b56dcf2e55554533a5f1130845390
ToppCellCOVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class

CUX2 MYO1E AFF3 IL3RA

8.78e-051865643db5ed69d49e5d79f990aca0295ddce4c297a05c
ToppCellIIH-pDC-|IIH / Condition, Cell_class and T cell subcluster

CUX2 MYO1E AFF3 IL3RA

8.96e-05187564ad87b146ea8dd9f695e722f8f0e8e1057c7f3167
ToppCellIIH-pDC|IIH / Condition, Cell_class and T cell subcluster

CUX2 MYO1E AFF3 IL3RA

8.96e-051875645e59e9153a18bcfb5c8dc94599080216661de7ce
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MYO10 UNC5C AFF3 SCN7A

8.96e-05187564a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYH9 MYO10 DYSF IL3RA

8.96e-051875640ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

MYH9 EYA4 AFF3 DYSF

9.15e-051885646d249fe92d51a19da19ec14bb2262d394255d577
ToppCellPBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

9.15e-0518856489411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCellCOVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type

HOXD3 UNC5C HLF ARNT2

9.15e-05188564df1fd0819d301679f3c9ea404e942e39095912eb
ToppCellPBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

9.15e-05188564de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCellCOVID-19_Severe-pDC|World / disease group, cell group and cell class

CUX2 MYO1E AFF3 IL3RA

9.15e-051885644c8e328b8206120708b05ea3c5865a0200dc5c4e
ToppCellPBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

9.15e-05188564879054b780378ae05be68e597c77c931bf0ade03
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EYA4 MYO1E MYO10 EYA3

9.15e-05188564e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCellPBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

9.34e-05189564209cae68d78c8f72479b169e27c3ff7e143adece
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HOXD3 HLF ARNT2 SCN7A

9.34e-05189564975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYH9 SPNS2 DYSF IL3RA

9.34e-05189564fccadf8efbef17b7f12291b069c71060a71b04e2
ToppCellPBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

9.34e-05189564a9ad1fb12304541f909dd0eeac9b9eb28c31fd41
ToppCellPBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

9.34e-0518956498ca646231fbd5f29827c2dd31ac4503026bad7d
ToppCellPBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

9.53e-05190564adffa93635da10251f28b2089fd96b189775c8b4
ToppCellPBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

9.53e-051905649a91bf1ea105029e6412d0d9060bca325299ce26
ToppCellControl-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

MYH9 MYO10 SYNE1 AFF3

9.53e-051905647f3f419fffe02934b6f27b697f7a6401072491ed
ToppCellPBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

9.53e-0519056439c8ddc2639bf3e986dae11fbae61a735614b604
ToppCellPBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

9.53e-051905642c1c079fd411c03bc3f383aa927eea9446716960
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EYA4 MYO1E MYO10 EYA3

9.53e-0519056411d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH9 HLF SCN7A ITGA9

9.53e-05190564d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue

CUX2 MYO1E AFF3 IL3RA

9.53e-051905646892c603037b61ef88d6ca01b7592dc0d347d63b
ToppCellPBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CUX2 MYO1E AFF3 IL3RA

9.53e-05190564a95aea3aa707fc4574810706341a5f32b3d00209
ToppCellPBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CUX2 MYO1E AFF3 IL3RA

9.53e-0519056418dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCellCOVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class

CUX2 MYO1E AFF3 IL3RA

9.53e-05190564c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EYA4 MYO1E MYO10 EYA3

9.53e-05190564b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84
ToppCellCOVID-19_Moderate-pDC|World / disease group, cell group and cell class

CUX2 MYO1E AFF3 IL3RA

9.73e-0519156493adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ASPM PWWP3A CLINT1 FAM111B

9.73e-05191564588015d76b68488da6aa6603777682f3d81592bf
ToppCellCOVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

SPNS2 SYNE1 AFF3 DYSF

1.01e-04193564979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYO10 UNC5C AFF3 ARNT2

1.03e-04194564b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH9 AFF3 ITGA9 DYSF

1.03e-04194564a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPNS2 SYNE1 AFF3 DYSF

1.03e-0419456440842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

EYA4 MYO10 UNC5C AFF3

1.05e-04195564c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCellPCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

EYA4 UNC5C AFF3 SCN7A

1.07e-04196564dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

MYO10 UNC5C AFF3 SCN7A

1.07e-0419656422538376a95fe3afe8639a216a5497087aa94110
ToppCellmyeloid-pro-pDC|myeloid / Lineage and Cell class

AFF3 ASPM IL3RA FAM111B

1.07e-0419656470daf4fabb68aecc5cc9f03d6f6495dd29b74a16
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYO10 UNC5C AFF3 SCN7A

1.10e-0419756431a1852911bda38543916585fda34255fd62a134
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CUX2 MYO1E AFF3 FES

1.10e-0419756489fe4885efc8db142c0dc0506840ae8aceba9ef9
ToppCellPBMC-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO1E CARD9 AFF3 FES

1.10e-0419756422e4ffb5de483eaf78f14badf3d08db898e3b3dd
ToppCellmyeloid-pro-pDC|World / Lineage and Cell class

CUX2 ASPM IL3RA FAM111B

1.10e-041975648918ee006b16f6b86ed33ce1dd5c0f01f51f88f5
Drugformycin triphosphate

MYH9 MYO1D MYO1E MYO10

7.00e-0651554CID000122274
Drugblebbistatin

MYH9 MYO1D MYO1E MYO10 ITGA9

8.94e-06116555CID003476986
DrugB0683

MYH9 MYO1D MYO1E MYO10 ITGA9

9.32e-06117555CID006398969
Drugpurealin

MYH9 MYO1D MYO1E MYO10

1.17e-0558554CID006419303
Drugclenbuterol

MYH9 MYO1D MYO1E MYO10 SCN7A

2.38e-05142555CID000002783
Diseaseeye disease (implicated_via_orthology)

EYA4 EYA3

4.91e-056542DOID:5614 (implicated_via_orthology)
Diseasebranchiootorenal syndrome (implicated_via_orthology)

EYA4 EYA3

6.86e-057542DOID:14702 (implicated_via_orthology)
DiseaseMAJOR AFFECTIVE DISORDER 2

CUX2 ITGA9

4.39e-0417542C1839839
Diseasemuscular dystrophy (is_implicated_in)

SYNE1 DYSF

4.39e-0417542DOID:9884 (is_implicated_in)
DiseasePrimary microcephaly

TUBGCP3 ASPM

7.42e-0422542C0431350
DiseaseHyalinosis, Segmental Glomerular

MYH9 MYO1E

1.21e-0328542C0086432
Diseaseanterior thigh muscle fat infiltration measurement

EYA4 DYSF

1.21e-0328542EFO_0020936
DiseaseAutosomal dominant nonsyndromic hearing loss

MYH9 EYA4

1.29e-0329542cv:C5779548
DiseaseNEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE

MYO1E XPO5

1.38e-0330542C1868672
Diseasesensorineural hearing loss (is_implicated_in)

MYH9 EYA4

1.67e-0333542DOID:10003 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
RCLALLYWRMFRLKR

AFF3

1066

P51826
LYWRMFRLKRDHAVK

AFF3

1071

P51826
AFLNARRKEMLYKRW

FAM228B

66

P0C875
PRFLAYMEDRRKQKW

CHD8

2351

Q9HCK8
MNRRKFLYQFKNVRW

AICDA

6

Q9GZX7
YFLMAKRAVRGWSRL

ADCK5

501

Q3MIX3
GSMFQYWKRFDLRRL

CUX2

6

O14529
NYRRKRALRKMQKGW

CARD9

501

Q9H257
TIKIQAMWRRYRAKK

ASPM

2936

Q8IZT6
QLMLLLWKNFMYRRR

ABCA7

6

Q8IZY2
YRFRTKNREWMLIRT

ARNT2

401

Q9HBZ2
YDKRLWPRMDLSRRK

FBXL19

456

Q6PCT2
LWHTMKNYYRILMRR

RANBP2

2961

P49792
WMRKLAFRYRKVREI

EYA3

411

Q99504
GWNLRKVQYFLMAKR

EPM2A

286

O95278
SRMLKDNKKNWRRVY

CLINT1

66

Q14677
MQALSWRKLYLSRAK

ORAI1

71

Q96D31
MARVYNWDVKRRNKD

VBP1

176

P61758
KRWFVLRQSKLMYFE

MYO10

1236

Q9HD67
LRVFNFLWRAKRMEY

TUBGCP3

661

Q96CW5
ALAKATYERMFRWLV

MYH9

416

P35579
RQIKIWFQNRRMKYK

HOXD3

236

P31249
MLKYALKERWNRRHE

GNMT

91

Q14749
DKYWARRRKNNMAAK

HLF

226

Q16534
KRKARGTMVRWLRAY

PORCN

231

Q9H237
LWKMGFFRRRYKEII

ITGA9

1001

Q13797
NDPRWKRYRRWMKNE

DNAJC25

336

Q9H1X3
DWMRKLAFRYRRVKE

EYA4

476

O95677
WKMRSHFNRKFRYEL

IL3RA

226

P26951
NKRQNGRLMWLYLKY

CCDC127

226

Q96BQ5
DAHYRRQLRWKMLQK

HAP1

636

P54257
WKLGMNKRSLRYIKR

GLYATL1B

186

A0A0U1RQE8
WVRKYFREEQKRMNL

FAM111B

411

Q6SJ93
EKMYYTHRRRRWVRL

DYSF

1031

O75923
VRALNPLDYMKWRRK

SLC8B1

306

Q6J4K2
RKWMAQRVKSDREYA

FES

31

P07332
MADAKYVLCRWEKRL

PWWP3A

1

Q2TAK8
REKAKAFWAMRRSYE

TRIM35

156

Q9UPQ4
ARYLKKKNMRTLWIN

MRPL20

56

Q9BYC9
SWKKLRYFRLQNDGM

PLCD4

31

Q9BRC7
QRYREMAEKLRKWLV

SYNE1

7566

Q8NF91
YYKDQWRPRKFKMRQ

NXPE3

326

Q969Y0
RGRAWLYLALMQKKL

RUFY1

206

Q96T51
SWLRDMKALIRNRSY

SPNS2

301

Q8IVW8
LLFKWRNMADRYERL

CTPS2

281

Q9NRF8
RQNWPEDKRRYFIKM

POLK

211

Q9UBT6
KFRWNGMSRLEKVYL

XPO5

76

Q9HAV4
WKDDFALNSMLRRRF

YJU2B

176

P13994
RKWYSRKDLARHRMQ

ZNF598

161

Q86UK7
RLFRMLRIFKLGKYW

SCN7A

596

Q01118
ILFYKMREEQLRRWK

SH2D4B

26

Q5SQS7
MAKLWFKFQRYFRRK

WSCD2

1

Q2TBF2
KKTGFRYALQVWRLM

PTCD1

296

O75127
WRMLAHKLNLDRYLN

UNC5C

866

O95185
LYWINKRRRYGMNAA

TEX38

66

Q6PEX7
QKVWRGTLARMRYKR

MYO1D

706

O94832
WRKFVARKKYVQMRE

MYO1E

706

Q12965